These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy. Mao F; Robinson JL; Unger T; Posavi M; Amado DA; Elman L; Grossman M; Wolk DA; Lee EB; Van Deerlin VM; Porta S; Lee VMY; Trojanowski JQ; Chen-Plotkin AS Acta Neuropathol; 2021 Oct; 142(4):629-642. PubMed ID: 34152475 [TBL] [Abstract][Full Text] [Related]
6. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. van Blitterswijk M; Mullen B; Nicholson AM; Bieniek KF; Heckman MG; Baker MC; DeJesus-Hernandez M; Finch NA; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R Acta Neuropathol; 2014 Mar; 127(3):397-406. PubMed ID: 24385136 [TBL] [Abstract][Full Text] [Related]
8. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706 [TBL] [Abstract][Full Text] [Related]
9. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis. Root J; Merino P; Nuckols A; Johnson M; Kukar T Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000 [TBL] [Abstract][Full Text] [Related]
10. Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases. Dedeene L; Van Schoor E; Vandenberghe R; Van Damme P; Poesen K; Thal DR Acta Neuropathol Commun; 2019 Dec; 7(1):189. PubMed ID: 31791419 [TBL] [Abstract][Full Text] [Related]
11. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254 [TBL] [Abstract][Full Text] [Related]
12. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain. Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750 [TBL] [Abstract][Full Text] [Related]
13. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Van Deerlin VM; Sleiman PM; Martinez-Lage M; Chen-Plotkin A; Wang LS; Graff-Radford NR; Dickson DW; Rademakers R; Boeve BF; Grossman M; Arnold SE; Mann DM; Pickering-Brown SM; Seelaar H; Heutink P; van Swieten JC; Murrell JR; Ghetti B; Spina S; Grafman J; Hodges J; Spillantini MG; Gilman S; Lieberman AP; Kaye JA; Woltjer RL; Bigio EH; Mesulam M; Al-Sarraj S; Troakes C; Rosenberg RN; White CL; Ferrer I; Lladó A; Neumann M; Kretzschmar HA; Hulette CM; Welsh-Bohmer KA; Miller BL; Alzualde A; Lopez de Munain A; McKee AC; Gearing M; Levey AI; Lah JJ; Hardy J; Rohrer JD; Lashley T; Mackenzie IR; Feldman HH; Hamilton RL; Dekosky ST; van der Zee J; Kumar-Singh S; Van Broeckhoven C; Mayeux R; Vonsattel JP; Troncoso JC; Kril JJ; Kwok JB; Halliday GM; Bird TD; Ince PG; Shaw PJ; Cairns NJ; Morris JC; McLean CA; DeCarli C; Ellis WG; Freeman SH; Frosch MP; Growdon JH; Perl DP; Sano M; Bennett DA; Schneider JA; Beach TG; Reiman EM; Woodruff BK; Cummings J; Vinters HV; Miller CA; Chui HC; Alafuzoff I; Hartikainen P; Seilhean D; Galasko D; Masliah E; Cotman CW; Tuñón MT; Martínez MC; Munoz DG; Carroll SL; Marson D; Riederer PF; Bogdanovic N; Schellenberg GD; Hakonarson H; Trojanowski JQ; Lee VM Nat Genet; 2010 Mar; 42(3):234-9. PubMed ID: 20154673 [TBL] [Abstract][Full Text] [Related]
14. Clinical and neuropathological features of ALS/FTD with TIA1 mutations. Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908 [TBL] [Abstract][Full Text] [Related]
15. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785 [TBL] [Abstract][Full Text] [Related]
16. Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations and C9orf72 repeat expansions. Lattante S; Le Ber I; Galimberti D; Serpente M; Rivaud-Péchoux S; Camuzat A; Clot F; Fenoglio C; ; Scarpini E; Brice A; Kabashi E Neurobiol Aging; 2014 Nov; 35(11):2658.e1-2658.e5. PubMed ID: 25085782 [TBL] [Abstract][Full Text] [Related]
17. What we know about TMEM106B in neurodegeneration. Nicholson AM; Rademakers R Acta Neuropathol; 2016 Nov; 132(5):639-651. PubMed ID: 27543298 [TBL] [Abstract][Full Text] [Related]
18. The TMEM106B locus and TDP-43 pathology in older persons without FTLD. Yu L; De Jager PL; Yang J; Trojanowski JQ; Bennett DA; Schneider JA Neurology; 2015 Mar; 84(9):927-34. PubMed ID: 25653292 [TBL] [Abstract][Full Text] [Related]
19. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients. Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125 [TBL] [Abstract][Full Text] [Related]
20. TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia. Marks JD; Ayuso VE; Carlomagno Y; Yue M; Todd TW; Hao Y; Li Z; McEachin ZT; Shantaraman A; Duong DM; Daughrity LM; Jansen-West K; Shao W; Calliari A; Bejarano JG; DeTure M; Rawlinson B; Casey MC; Lilley MT; Donahue MH; Jawahar VM; Boeve BF; Petersen RC; Knopman DS; Oskarsson B; Graff-Radford NR; Wszolek ZK; Dickson DW; Josephs KA; Qi YA; Seyfried NT; Ward ME; Zhang YJ; Prudencio M; Petrucelli L; Cook CN Sci Transl Med; 2024 Jan; 16(730):eadf9735. PubMed ID: 38232138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]